Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

946 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Editorial: Autoimmune Blistering Diseases.
Kowalewski C, Hashimoto T, Joly P. Kowalewski C, et al. Among authors: joly p. Front Immunol. 2020 Jul 22;11:1614. doi: 10.3389/fimmu.2020.01614. eCollection 2020. Front Immunol. 2020. PMID: 32793239 Free PMC article. No abstract available.
Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts.
Murrell DF, Daniel BS, Joly P, Borradori L, Amagai M, Hashimoto T, Caux F, Marinovic B, Sinha AA, Hertl M, Bernard P, Sirois D, Cianchini G, Fairley JA, Jonkman MF, Pandya AG, Rubenstein D, Zillikens D, Payne AS, Woodley D, Zambruno G, Aoki V, Pincelli C, Diaz L, Hall RP, Meurer M, Mascaro JM Jr, Schmidt E, Shimizu H, Zone J, Swerlick R, Mimouni D, Culton D, Lipozencic J, Bince B, Grando SA, Bystryn JC, Werth VP. Murrell DF, et al. Among authors: joly p. J Am Acad Dermatol. 2012 Mar;66(3):479-85. doi: 10.1016/j.jaad.2011.06.032. Epub 2011 Nov 5. J Am Acad Dermatol. 2012. PMID: 22056920 Free PMC article.
Definitions and outcome measures for mucous membrane pemphigoid: recommendations of an international panel of experts.
Murrell DF, Marinovic B, Caux F, Prost C, Ahmed R, Wozniak K, Amagai M, Bauer J, Beissert S, Borradori L, Culton D, Fairley JA, Fivenson D, Jonkman MF, Marinkovich MP, Woodley D, Zone J, Aoki V, Bernard P, Bruckner-Tuderman L, Cianchini G, Venning V, Diaz L, Eming R, Grando SA, Hall RP, Hashimoto T, Herrero-González JE, Hertl M, Joly P, Karpati S, Kim J, Chan Kim S, Korman NJ, Kowalewski C, Lee SE, Rubenstein DR, Sprecher E, Yancey K, Zambruno G, Zillikens D, Doan S, Daniel BS, Werth VP. Murrell DF, et al. Among authors: joly p. J Am Acad Dermatol. 2015 Jan;72(1):168-74. doi: 10.1016/j.jaad.2014.08.024. Epub 2014 Nov 4. J Am Acad Dermatol. 2015. PMID: 25443626 Free article. Review.
Diagnosis and management of pemphigus: Recommendations of an international panel of experts.
Murrell DF, Peña S, Joly P, Marinovic B, Hashimoto T, Diaz LA, Sinha AA, Payne AS, Daneshpazhooh M, Eming R, Jonkman MF, Mimouni D, Borradori L, Kim SC, Yamagami J, Lehman JS, Saleh MA, Culton DA, Czernik A, Zone JJ, Fivenson D, Ujiie H, Wozniak K, Akman-Karakaş A, Bernard P, Korman NJ, Caux F, Drenovska K, Prost-Squarcioni C, Vassileva S, Feldman RJ, Cardones AR, Bauer J, Ioannides D, Jedlickova H, Palisson F, Patsatsi A, Uzun S, Yayli S, Zillikens D, Amagai M, Hertl M, Schmidt E, Aoki V, Grando SA, Shimizu H, Baum S, Cianchini G, Feliciani C, Iranzo P, Mascaró JM Jr, Kowalewski C, Hall R, Groves R, Harman KE, Marinkovich MP, Maverakis E, Werth VP. Murrell DF, et al. Among authors: joly p. J Am Acad Dermatol. 2020 Mar;82(3):575-585.e1. doi: 10.1016/j.jaad.2018.02.021. Epub 2018 Feb 10. J Am Acad Dermatol. 2020. PMID: 29438767 Free PMC article.
Impact of COVID-19 on autoimmune blistering diseases.
Drenovska K, Vassileva S, Tanev I, Joly P. Drenovska K, et al. Among authors: joly p. Clin Dermatol. 2021 May-Jun;39(3):359-368. doi: 10.1016/j.clindermatol.2021.01.007. Epub 2021 Feb 2. Clin Dermatol. 2021. PMID: 34517993 Free PMC article.
The Diversity of Serum Anti-DSG3 IgG Subclasses Has a Major Impact on Pemphigus Activity and Is Predictive of Relapses After Treatment With Rituximab.
Golinski ML, Lemieux A, Maho-Vaillant M, Barray M, Drouot L, Schapman D, Petit M, Hertl M, Boyer O, Calbo S, Joly P, Hébert V. Golinski ML, et al. Among authors: joly p. Front Immunol. 2022 Mar 15;13:849790. doi: 10.3389/fimmu.2022.849790. eCollection 2022. Front Immunol. 2022. PMID: 35371083 Free PMC article.
FcRn Antagonism Leads to a Decrease of Desmoglein-Specific B Cells: Secondary Analysis of a Phase 2 Study of Efgartigimod in Pemphigus Vulgaris and Pemphigus Foliaceus.
Maho-Vaillant M, Sips M, Golinski ML, Vidarsson G, Goebeler M, Stoevesandt J, Bata-Csörgő Z, Balbino B, Verheesen P, Joly P, Hertl M, Calbo S. Maho-Vaillant M, et al. Among authors: joly p. Front Immunol. 2022 May 18;13:863095. doi: 10.3389/fimmu.2022.863095. eCollection 2022. Front Immunol. 2022. PMID: 35663943 Free PMC article. Clinical Trial.
How Do Experts Treat Patients with Bullous Pemphigoid around the World? An International Survey.
Guignant M, Tedbirt B, Murrell DF, Amagai M, Aoki V, Bauer J, Ciancinni G, Culton D, Daneshpazhooh M, De D, Fairley J, Hall R, Kim SC, Korman NJ, Kowalewski C, Mimouni D, Patsatsi A, Hebert V, Saleh MAM, Schmidt E, Sprecher E, Uzun S, Venning V, Werth VP, Zillikens D, Joly P. Guignant M, et al. Among authors: joly p. JID Innov. 2022 Apr 12;2(4):100129. doi: 10.1016/j.xjidi.2022.100129. eCollection 2022 Jul. JID Innov. 2022. PMID: 35860447 Free PMC article.
946 results